PRU
48
-3
PNW
48
-11
EXPD
42
2
HRB
65
-5
BA
38
2
APH
67
5
CFG
40
-6
CHK
41
2
EXC
61
-2
APA
50
4
AVGO
44
4
SBUX
50
-2
EW
40
-2
PYPL
45
-5
LNC
43
-3
UAL
58
2
AIV
61
10
OKE
73
2
BMY
33
-12
HST
50
-4
PRU
48
-3
PNW
48
-11
EXPD
42
2
HRB
65
-5
BA
38
2
APH
67
5
CFG
40
-6
CHK
41
2
EXC
61
-2
APA
50
4
AVGO
44
4
SBUX
50
-2
EW
40
-2
PYPL
45
-5
LNC
43
-3
UAL
58
2
AIV
61
10
OKE
73
2
BMY
33
-12
HST
50
-4
Financhill
Back

Catalyst Pharmaceuticals Vs. Merrimack Pharmaceuticals Industry Stock Comparison

Sell
41

CPRX
Catalyst Pharmaceuticals

Last Price:
14.90
Seasonality Move:
2.11%
Buy
55

MACK
Merrimack Pharmaceuticals

Last Price:
14.74
Seasonality Move:
-16.2%
Sell
41
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $14.68. The Score for CPRX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Merrimack Pharmaceuticals (MACK) is a Buy

Is Merrimack Pharmaceuticals a Buy, Sell or Hold?

  • The current Merrimack Pharmaceuticals [MACK] share price is $14.73. The Score for MACK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • MACK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $14.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

MACK Stock Price Chart

What is Merrimack Pharmaceuticals's stock price today?

  • The Merrimack Pharmaceuticals share price today is $14.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MACK is experiencing slight buying pressure.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 41.25 Sell
Chaikin Money Flow: -560167 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 15.98) Sell
Bollinger Bands (100): (14.04 - 16.2) Sell

MACK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 58.09 Buy
Chaikin Money Flow: 16478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.69 - 14.75) Buy
Bollinger Bands (100): (13.22 - 14.74) Buy

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.21 Sell
20-day SMA: 15.4 Sell
50-day SMA: 15.47 Sell
200-day SMA: 14.2 Buy
8-day EMA: 15.1 Sell
20-day EMA: 15.36 Sell
50-day EMA: 15.35 Sell
200-day EMA: 14.58 Buy

MACK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.71 Buy
20-day SMA: 14.71 Buy
50-day SMA: 14.71 Buy
200-day SMA: 13.12 Buy
8-day EMA: 14.71 Buy
20-day EMA: 14.7 Buy
50-day EMA: 14.51 Buy
200-day EMA: 13.28 Buy

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Merrimack Pharmaceuticals Earnings Growth & MACK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Merrimack Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):